Rate of telomere shortening and metabolic and cardiovascular risk factors: A longitudinal study in the 1934-44 Helsinki Birth Cohort Study

Annals of Medicine

Volumn 47, Issue 6, 2015, Pages 499-505

  Guzzardi, Maria Angela ^a   Iozzo, Patricia ^a   Salonen, Minna ^b,c   Kajantie, Eero ^b,d   Eriksson, Johan G ^b,c,e  

^a CNR   (Italy)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c FOLKHÄLSAN RESEARCH CENTER   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Adiposity; ageing; blood pressure; dyslipidaemia; telomere shortening

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; AGING; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY FAT; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CELL AGING; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; DIASTOLIC BLOOD PRESSURE; DRUG USE; FEMALE; FINLAND; FOLLOW UP; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LEAN BODY WEIGHT; LEUKOCYTE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TELOMERE; TELOMERE SHORTENING; WAIST CIRCUMFERENCE; AGE; BLOOD; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; GENETICS; METABOLISM; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; TELOMERE HOMEOSTASIS; ULTRASTRUCTURE;

ADIPOSITY; AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; COHORT STUDIES; FEMALE; FINLAND; HUMANS; LEUKOCYTES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; TRIGLYCERIDES;

EID: 84942984275     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2015.1074718     Document Type: Article

References (33)

1. United Nations, Department of Economic and Social Aff airs, Population Division. World Population Ageing 2013. Available at: http://www. un. org/en/development/desa/population/publications/pdf/ageing/ WorldPopulationAgeing2013. pdf United Nations, New York 2013.
2. W orld Health Organization (WHO). G lobal brief for World Health Day 2012: Good health adds life to years. Geneva: World Health Organization. Available at: http://apps. who. int/iris/bitstream/10665/70853/1/ WHO-DCO-WHD-2012. 2-eng. pdf WHO Geneva 2012.
3. Barnard ND, Bush AI, Ceccarelli A, Cooper J, de Jager CA, Erickson KI, et al. Dietary and lifestyle guidelines for the prevention of Alzheimer ' s disease. Neurobiol Aging. 2014; 35(Suppl 2): S74-8.
4. Bell SP, Saraf A. Risk stratifi cation in very old adults: how to best gauge risk as the basis of management choices for patients aged over 80. Prog Cardiovasc Dis. 2014; 57: 197-203.
5. Imtiaz B, Tolppanen AM, Kivipelto M, Soininen H. Future directions in Alzheimer ' s disease from risk factors to prevention. Biochem Pharmacol. 2014; 88: 661-70.
6. Robinson JG. Starting primary prevention earlier with statins. Am J Cardiol. 2014; 114: 1437-42.
7. Valdes AM, Andrew T, Gardner JP, Kimura M, Oelsner E, Cherkas LF, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005; 366: 662-4.
8. Kim S, Parks CG, DeRoo LA, Chen H, Taylor JA, Cawthon RM, et al. Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol Biomarkers Prev. 2009; 18: 816-20.
9. Gardner JP, Li S, Srinivasan SR, Chen W, Kimura M, Lu X, et al. Rise in insulin resistance is associated with escalated telomere attrition. Circulation. 2005; 111: 2171-7.
10. Demissie S, Levy D, Benjamin EJ, Cupples LA, Gardner JP, Herbert A, et al. Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell. 2006; 5: 325-30.
11. F itzpatrick A L, K ronmal R A, G ardner J P, P saty B M, J enny N S, T racy R P, et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol. 2007; 165: 14-21.
12. Ye S, Shaff er JA, Kang MS, Harlapur M, Muntner P, Epel E, et al. Relation between leukocyte telomere length and incident coronary heart disease events (from the 1995 Canadian Nova Scotia Health Survey). Am J Cardiol. 2013; 111: 962-7.
13. R é v é sz D, Milaneschi Y, Verhoeven JE, Penninx BW. Telomere length as a marker of cellular aging is associated with prevalence and progression of metabolic syndrome. J Clin Endocrinol Metab. 2014; 99: 4607-15.
14. Masi S, D' Aiuto F, Martin-Ruiz C, Kahn T, Wong A, Ghosh AK, et al. Rate of telomere shortening and cardiovascular damage: A longitudinal study in the 1946 British Birth Cohort. Eur Heart J. 2014; 35: 3296-303.
15. Cetin DC, Nasr G. Obesity in the elderly: more complicated than you think. Cleve Clin J Med. 2014; 81: 51-61.
16. Chapman IM. Obesity paradox during aging. Interdiscip Top Gerontol. 2010; 37: 20-36.
17. Rantanen KK, Strandberg TE, Stenholm SS, Strandberg AY, Pitkä lä KH, Salomaa VV, et al. Clinical and laboratory characteristics of active and healthy aging (AHA) in octogenarian men. Aging Clin Exp Res. 2015 Mar 1. [Epub ahead of print]
18. Barker DJP, Osmond C, Forsen TJ, Kajantie E, Eriksson JG. Trajectories of growth among children who have coronary events as adults. New Engl J Med. 2005; 353: 1802-9.
19. Ylihä rsilä H, Kajantie E, Osmond C, Barker DJP, Fors é n T, Eriksson JG. Body mass index during childhood and adult body composition in men and women aged 56 to 70 years. Am J Clin Nutr. 2008; 87: 1769-75.
20. Friedewald WT, Levy RI, Fredrickson RS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Clin Chem. 1972; 18: 499-502.
21. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002; 30: e47.
22. Kajantie E, Pietilä inen KH, Wehkalampi K, Kananen L, Rä ikk ö nen K, Rissanen A, et al. No association between body size at birth and leucocyte telomere length in adult life-evidence from three cohort studies. Int J Epidemiol. 2012; 41: 1400-8.
23. O' Callaghan N, Dhillon V, Th omas P, F enech M. A quantitative real-time PCR method for absolute telomere length. Biotechniques. 2008; 44: 807-9.
24. C awthon R M. T elomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res. 2009; 37: e21.
25. Chen S, Yeh F, Lin J, Matsuguchi T, Blackburn E, Lee ET, et al. Short leukocyte telomere length is associated with obesity in American Indians: the Strong Heart Family study. Aging (Albany NY). 2014; 6: 380-9.
26. M ü ezzinler A, Zaineddin AK, Brenner H. Body mass index and leukocyte telomere length in adults: A systematic review and meta-analysis. Obes Rev. 2014; 15: 192-201.
27. Olivieri F, Recchioni R, Marcheselli F, Abbatecola AM, Santini G, Borghetti G, et al. Cellular senescence in cardiovascular diseases: potential age-related mechanisms and implications for treatment. Curr Pharm Des. 2013; 19: 1710-19.
28. Babizhayev MA, Savel' yeva EL, Moskvina SN, Yegorov YE. Telomere length is a biomarker of cumulative oxidative stress, biologic age, and an independent predictor of survival and therapeutic treatment requirement associated with smoking behavior. Am J Th er. 2011; 18: e209-26.
29. von Zglinicki T. Oxidative stress shortens telomeres. T rends Biochem Sci. 2002; 27: 339-44.
30. M ü nzel T, Gori T, Bruno RM, Taddei S. Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J. 2010; 31: 2741-8.
31. Masi S, Salpea KD, Li K, Parkar M, Nibali L, Donos N, et al. Oxidative stress, chronic infl ammation, and telomere length in patients with periodontitis. Free Radic Biol Med. 2011; 50: 730-5.
32. Ehrlenbach S, Willeit P, Kiechl S, Willeit J, Reindl M, Schanda K, et al. Influences on the reduction of relative telomere length over 10 years in the population-based Bruneck Study: introduction of a well-controlled high-throughput assay. Int J Epidemiol. 2009; 38: 1725-34.
33. Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, et al. Eff ect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol. 2013; 14: 1112-20